References
- Vashi NA., Kundu RV. Facial hyperpigmentation: causes and treatment. Br J Dermatol [Internet]. 2013 Oct;169(s3):41–56. accessed 2017 Mar 6. doi: 10.1111/bjd.12536.
- Handel AC, Miot LDB, Miot HA. Melasma: a clinical and epidemiological review. An Bras Dermatol. 2014;89(5):771–82. doi:10.1590/abd1806-4841.20143063.
- Goglia L, Bernacchi G, Gianfaldoni S. Melasma : a cosmetic stigma during pregnancy. J Pigment Disord. 2014;S1:1–4.
- Cestari T, Arellano I, Hexsel D, Ortonne J, Latin American Pigmentary Disorders Academy. Melasma in Latin America: options for therapy and treatment algorithm. J Eur Acad Dermatology Venereol [Internet]. 2009 Jul ;23(7):760–72. [accessed 2017 Mar 6]. http://www.ncbi.nlm.nih.gov/pubmed/19646135.
- D’Elia MPB, Brandão MC, de Andrade Ramos BR, Da Silva MG, Miot LDB, dos Santos SEB, et al. African ancestry is associated with facial melasma in women: a cross-sectional study. BMC Med Genet [Internet]. 2017 Dec 17;18(1):17. accessed 2017 Mar 6. doi:10.1186/s12881-017-0378-7.
- Park KC, Kim IS. Pathogenesis of melasma. In: Evangeline B. HandogMaria Juliet Enriquez-Macarayo (Eds.), Melasma and Vitiligo in brown skin [Internet]. New Delhi: Springer India; 2017. p. 21–31.cited 2017 Mar 6. Available from doi:10.1007/978-81-322-3664-1_4.
- Gupta S, Mahendra A, AJ-TP, 2017 undefined. A study of the clinical profile and assessment of the quality of life in patients of melasma. search.proquest.com [Internet]. [cited 2018 May 1]; http://search.proquest.com/openview/f00c1c1ac465e3feec0b84e75fc1e54c/1?pq-origsite=gscholar&cbl=1176347
- Rostami Mogaddam M, Iranparvar Alamdari M, Maleki N, Safavi Ardabili N, Abedkouhi S. Evaluation of autoimmune thyroid disease in melasma. J Cosmet Dermatol [Internet]. 2015 Jun;14(2):167–71. accessed 2017 Mar 6. Doi:10.1111/jocd.12138.
- Torok HM. A comprehensive review of the long-term and short-term treatment of melasma with a triple combination cream. Am J Clin Dermatol [Internet]. 2006 [cited 2017 Mar 6];7(4):223–30. doi:10.2165/00128071-200607040-00003.
- Arefiev KLB, Hantash BM. Advances in the treatment of melasma: a review of the recent literature. Dermatologic Surg [Internet]. 2012 Jul;38(7pt1):971–84. accessed 2017 Mar 6. http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00042728-201207010-00001.
- Rivas S, Pandya AG. Treatment of melasma with topical agents, peels and lasers: an evidence-based review. Am J Clin Dermatol [Internet]. 2013 Oct 24;14(5):359–76. accessed 2017 Mar 6. doi:10.1007/s40257-013-0038-4.
- Goldberg DJ. Nonablative laser surgery for pigmented skin. Dermatologic Surg [Internet]. 2006 Mar 21;31(10):1263–67. accessed 2018 May 1. doi:10.1111/j.1524-4725.2005.31201.
- Dunbar S, Posnick D, Bloom B, Elias C, Zito P, Goldberg DJ. Energy-based device treatment of melasma: an update and review of the literature. J Cosmet Laser Ther [Internet]. 2017 Jan 2;19(1):2–12. accessed 2018 May 1. doi:10.1080/14764172.2016.1229485.
- Goldberg D, Metzler C. Skin resurfacing utilizing a low-fluence Nd: YAG laser. J Cutan Laser Ther [Internet]. 1999 Jan 12;1(1):23–27. accessed 2018 May 1 . doi:10.1080/14628839950517057.
- Polnikorn N. Treatment of refractory dermal melasma with the MedLite C6 Q‐switched Nd: YAG laser: two case reports. J Cosmet Laser Ther [Internet]. 2008 Jan 12;10(3):167–73. accessed 2017 Mar 6. doi;10.1080/14764170802179687.
- Choi M, Choi J-W, Lee S-Y, Choi S-Y, Park H-J, Park K-C, Youn S-W, Huh C-H. Low-dose 1064-nm Q-switched Nd: YAG laser for the treatment of melasma. J Dermatolog Treat [Internet]. 2010 Jul 30;21(4):224–28. accessed 2018 May 1. doi:10.3109/09546630903401462.
- Cho S, Kim J, Experimental MK-C and, 2009 undefined. Melasma treatment in Korean women using a 1064‐nm Q‐switched Nd: YAG laser with low pulse energy. Wiley Online Libr [Internet]. [ cited 2018 May 1].doi:10.1111/j.1365-2230.2009.03599.x
- WATTANAKRAI P, MORNCHAN R, EIMPUNTH S. Low-fluence q-switched neodymium-doped yttrium aluminum garnet (1,064 nm) laser for the treatment of facial melasma in Asians. Dermatologic Surg [Internet]. 2010 Jan;36(1):76–87. accessed 2018 May 1. http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00042728-201001000-00012.
- Kang H, Kim J, Goo B. The dual toning technique for melasma treatment with the 1064 nm Nd: YAG laser: a preliminary study. LASER Ther [Internet]. 2011;20(3):189–94. cited 2017 Mar 6. http://joi.jlc.jst.go.jp/JST.JSTAGE/islsm/20.189?from=CrossRef.
- Rivera Z, Isabel H, Rivera I, Ollarves V. Tratamiento del melasma en pacientes venezolanas utilizando láser Nd: YAG 1064nm en modo Q-switched. Dermatología Venez [Internet]. 2015;53(2). accessed 2017 Mar 6. http://revista.svderma.org/index.php/ojs/article/view/1351.
- Tian B. Laser toning for melasma: A single-centre experience with 38 970 cases. J Cosmet Laser Ther [Internet]. 2017 Feb. 1–3. accessed 2017 Mar 6. doi:10.1080/14764172.2016.1262960.
- Kim JE, Chang SE, Yeo UC, Haw S, Kim I-H. Histopathological study of the treatment of melasma lesions using a low-fluence Q-switched 1064-nm neodymium: yttrium-aluminium-garnetlaser. Clin Exp Dermatol [Internet]. 2013 Mar;38(2):167–71. accessed 2018 May 1. doi:10.1111/j.1365-2230.2012.04473.x.
- Parra C, Careta M, Valente N. Clinical and histopathologic assessment of facial melasma after low-fluence Q-switched neodymium-doped yttrium aluminium garnet laser. Dermatologic [Internet]. 2016. accessed 2017 Mar 6. http://journals.lww.com/dermatologicsurgery/Abstract/2016/04000/Clinical_and_Histopathologic_Assessment_of_Facial.10.aspx.
- Sarkar R, Aurangabadkar S, Salim T, D, et al. Lasers in melasma: a review with consensus recommendations by indian pigmentary expert group. Indian J Dermatol [Internet]. 2017;62(6):585–90. accessed 2018 May 1. http://www.ncbi.nlm.nih.gov/pubmed/29263531.
- Kong SH, Suh HS, Choi YS. Treatment of melasma with pulsed-dye laser and 1,064-nm Q-switched Nd: YAG Laser: a split-face study. Ann Dermatol [Internet]. 2018;30(1):1. accessed 2018 Apr 30. https://synapse.koreamed.org/DOIx.php?id=10.5021/ad.2018.30.1.1.
- Anderson RR, Margolis RJ, Watenabe S, Flotte T, Hruza GJ, Dover JS. Selective photothermolysis of cutaneous pigmentation by Q-switched Nd: YAG laser pulses at 1064, 532. and 355nm. J Invest Dermatol [Internet]. 1989 Jul;93(1):28–32. accessed 2017 Mar 6. http://linkinghub.elsevier.com/retrieve/pii/S0022202X89900791.
- Mun JY, Jeong SY, Kim JH, Han SS, Kim I-H. A low fluence Q-switched Nd: YAG laser modifies the 3D structure of melanocyte and ultrastructure of melanosome by subcellular-selective photothermolysis. J Electron Microsc (Tokyo) [Internet]. 2011 Feb 1;60(1):11–18. accessed 2018 May 2. https://academic.oup.com/jmicro/article-lookup/doi/10.1093/jmicro/dfq068.
- XI Z, GOLD MH, ZHONG L, YING L. Efficacy and safety of Q-switched 1,064-nm neodymium-doped yttrium aluminum garnet laser treatment of melasma. Dermatologic Surg [Internet]. 2011 Jun;37(7):962–70. accessed 2017 Mar 6. http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00042728-201106280-00009.
- Pelletier G, Ren L. Localization of sex steroid receptors in human skin. Histol Histopathol [Internet]. 2004. accessed 2017 Mar 6. https://digitum.um.es/xmlui/handle/10201/21548.
- Thornton MJ. Estrogens and aging skin. Dermatoendocrinol [Internet]. 2013 Apr 27;5(2):264–70. accessed 2017 Mar 6. doi:10.4161/derm.23872.
- Jang Y, Lee J, Kang H, Lee E-S KY. Oestrogen and progesterone receptor expression in melasma: an immunohistochemical analysis. J Eur Acad Dermatology Venereol [Internet]. 2010 Nov;24(11):1312–16. accessed 2017 Mar 6. DOI:10.1111/j.1468-3083.2010.03638.x.
- Lee A-Y. Recent progress in melasma pathogenesis. Pigment Cell Melanoma Res [Internet]. 2015 Nov;28(6):648–60. accessed 2017 Mar 6. doi:10.1111/pcmr.12404.
- Çakmak SK, Özcan N, Kılıç A, Koparal S, Artüz F, Çakmak A, Köse K. Etiopathogenetic factors, thyroid functions and thyroid autoimmunity in melasma patients. Adv Dermatology Allergol [Internet]. 2015;5:327–30. accessed 2017 Mar 6. doi:10.5114/pdia.2015.54742.
- Martin N, Smith K, Bloom S, Small C. Interactions between the melanocortin system and the hypothalamo–pituitary–thyroid axis. Peptides [Internet]. 2006. accessed 2017 Mar 6. http://www.sciencedirect.com/science/article/pii/S0196978105004456.
- Malek J, Chedraoui A, Nikolic D, Barouti N, Ghosn S, Abbas O. Successful treatment of hydroquinone-resistant melasma using topical methimazole. Dermatol Ther [Internet]. 2013 Jan;26(1):69–72. accessed 2017 Mar 6. doi:10.1111/j.1529-8019.2012.01540.x.
- Kawaguchi M, Suzuki T. Melanogenesis and new signaling regulators for the treatment of melasma. In: Evangeline B. HandogMaria Juliet Enriquez-Macarayo (Eds.), Melasma and vitiligo in brown skin [Internet]. New Delhi, India: Springer; 2017. p. 85–92.cited 2017 Mar 6. doi:10.1007/978-81-322-3664-1_11.
- Hassan AM, Elfar NN, Rizk OM, Eissa NY. Pulsed dye laser versus intense pulsed light in melasma: a split-face comparative study. J Dermatolog Treat [Internet]. 2018 Feb 23. 1–8. accessed 2018 Apr 30. doi:10.1080/09546634.2018.1441487.